Motorized spiral enteroscopy: results of an international multicenter prospective observational clinical study in patients with normal and altered gastrointestinal anatomy.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 23 4 2022
medline: 2 12 2022
entrez: 22 4 2022
Statut: ppublish

Résumé

BACKGROUND : Motorized spiral enteroscopy (MSE) has been shown to be safe and effective for deep enteroscopy in studies performed at expert centers with limited numbers of patients without previous abdominal surgery. This study aimed to investigate the safety, efficacy, and learning curve associated with MSE in a real-life scenario, with the inclusion of patients after abdominal surgery and with altered anatomy. METHODS : Patients with indications for deep enteroscopy were enrolled in a prospective observational multicenter study. The primary objective was the serious adverse event (SAE) rate; secondary objectives were the diagnostic and therapeutic yield, procedural success, time, and insertion depth. Data analysis was subdivided into training and core (post-training) study phases at centers with different levels of MSE experience. RESULTS : 298 patients (120 women; median age 68, range 19-92) were enrolled. In the post-training phase, 21.5 % (n = 54) had previous abdominal surgery, 10.0 % (n = 25) had surgically altered anatomy. Overall, SAEs occurred in 2.3 % (7/298; 95 %CI 0.9 %-4.8 %). The SAE rate was 2.0 % (5/251) in the core group and 4.3 % (2/47) in the training group, and was not increased after abdominal surgery (1.9 %). Total enteroscopy was achieved in half of the patients (n = 42) undergoing planned total enteroscopy. In 295/337 procedures (87.5 %), the anatomical region of interest could be reached. CONCLUSIONS : This prospective multicenter study showed that MSE was feasible and safe in a large cohort of patients in a real-life setting, after a short learning curve. MSE was shown to be feasible in postsurgical patients, including those with altered anatomy, without an increase in the SAE rate.

Identifiants

pubmed: 35451040
doi: 10.1055/a-1831-6215
doi:

Banques de données

ClinicalTrials.gov
['NCT03955081']

Types de publication

Observational Study Multicenter Study Clinical Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1147-1155

Commentaires et corrections

Type : CommentIn

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

T. Beyna, J. Devière, and H. Neuhaus have received consultancy honoraria and lecture fees from Olympus Medical Systems Corporation. M. Arvanitakis and M. Schneider have received lecture fees from Olympus. Andrea May has received lecture fees from Olympus and Fujifilm and research grants from Fujifilm. The remaining other authors declare that they have no conflict of interest

Auteurs

Torsten Beyna (T)

Department of Internal Medicine and Gastroenterology, Evangelisches Krankenhaus Düsseldorf, Germany.

Tom Moreels (T)

Department of Gastroenterology and Hepatology, Hospital Department Clinique Universitaires Saint-Luc Université, Brussels, Belgium.

Marianna Arvanitakis (M)

Department of Gastroenterology and Hepato-Pancreatology, Université Libre des Bruxelles, Erasme Hospital, Brussels, Belgium.

Mathieu Pioche (M)

Department of Digestive Diseases, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.

Jean-Christophe Saurin (JC)

Department of Digestive Diseases, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.

Andrea May (A)

Department of Internal Medicine II, Sana Klinikum Offenbach GmbH, Offenbach, Germany.
Department of Gastroenterology, Asklepios Paulinen Klinik, Wiesbaden, Germany.

Mate Knabe (M)

Department of Internal Medicine II, Sana Klinikum Offenbach GmbH, Offenbach, Germany.
Department of Gastroenterology and Hepatology, Center of Internal Medicine, Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany.

Jørgen Steen Agnholt (JS)

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Niels Christian Bjerregaard (NC)

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Lauri Puustinen (L)

Division of Gastroenterology, Helsinki University Central Hospital, Helsinki, Finland.

Christoph Schlag (C)

Department of Internal Medicine II, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Department of Gastroenterology and Endoscopy, Universitätsspital Zürich, Zurich, Switzerland.

Lars Aabakken (L)

Institute of Clinical Medicine, OUS-Rikshospitalet University Hospital, Oslo, Norway.

Vemund Paulsen (V)

Institute of Clinical Medicine, OUS-Rikshospitalet University Hospital, Oslo, Norway.

Markus Schneider (M)

Department of Internal Medicine and Gastroenterology, Evangelisches Krankenhaus Düsseldorf, Germany.

Markus F Neurath (MF)

Department of Internal Medicine I for Gastroenterology, Pulmonology and Endocrinology, University Hospital Erlangen, Erlangen, Germany.

Timo Rath (T)

Department of Internal Medicine I for Gastroenterology, Pulmonology and Endocrinology, University Hospital Erlangen, Erlangen, Germany.

Jacques Devière (J)

Department of Gastroenterology and Hepato-Pancreatology, Université Libre des Bruxelles, Erasme Hospital, Brussels, Belgium.

Horst Neuhaus (H)

Department of Internal Medicine and Gastroenterology, Evangelisches Krankenhaus Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH